| Volume: | 2,719,657 |
|---|---|
| Day's Low: | $54.34 |
| 52-wk Low: | $45.46 |
| Previous Close: | $54.84 |
| Dividend: | $0.26 |
| Market Cap: | 33,229,700 |
| Avg Volume: | 4,097,100 |
|---|---|
| Day's High: | $55.19 |
| 52-wk High: | $62.50 |
| Open Price: | $54.80 |
| Yield: | 1.89% |
| P/E (Forward): | 14.51 |
| 6:36 PM | 10/29/2009 | Baxter: Received Subpoena Regarding 'Colleague' Pumps |
| 12:21 PM | 10/29/2009 | UK Government: New Cases Of Swine Flu Still Rising |
| 11:27 AM | 10/23/2009 | 2nd UPDATE: EU Regulator Backs 2 Shots Of Swine Flu Vaccine |
| 10:13 AM | 10/23/2009 | UPDATE: EU Regulator Recommends 2 Shots Of Swine Flu Vaccine |
| 9:48 AM | 10/23/2009 | EU Health Regulator Recommends Two Shots Of Swine Flu Vaccine |
| 6:37 PM | 10/21/2009 | UPDATE: Edwards Lifesciences 3Q Profit Jumps; Outlook Raised |
| 11:53 AM | 10/20/2009 | UPDATE: FDA: Baxter Failed To Follow Good Manufacturing Practices |
| 11/7/2009 | Time to Order the Top-Shelf Stuff |
| 11/2/2009 | Jittery Companies Stash Cash |
| 11/2/2009 | Turnaround Letter not for faint of heart |
| 10/22/2009 | Baxter's key is versatility |
| 10/16/2009 | Oil Boosts Chevron; Goldman Falls 1.9% |
| 10/15/2009 | Updates, advisories and surprises |
| 10/15/2009 | Drug stocks gain; Baxter slides on earnings report |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.98 | 0.88 | 11.36 |
| EPS, GAAP | 0.87 | 0.74 | 17.57 |
| Consensus Estimate | 0.96 | 0.82 | 17.07 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.68 | 3.38 | 8.88 |
| EPS, GAAP | 3.56 | 3.00 | 18.67 |
| Consensus Estimate | 3.60 | NA | NA |
| BAX | Industry Average | |
| P/E (TTM) | 15.48 | 46.50 |
| P/E (Forward) | 14.51 | 13.00 |
| PEG Ratio | 1.24 | 0.74 |
| Price/Sales | 2.76 | 2.57 |
| Beta | 0.43 | 0.40 |